Kakitani M - Search Results

1

Craniofacial malformation in R-spondin2 knockout mice.

Yamada W, Nagao K, Horikoshi K, Fujikura A, Ikeda E, Inagaki Y, Kakitani M, Tomizuka K, Miyazaki H, Suda T, Takubo K. Yamada W, et al. Among authors: kakitani m. Biochem Biophys Res Commun. 2009 Apr 10;381(3):453-8. doi: 10.1016/j.bbrc.2009.02.066. Epub 2009 Feb 20. Biochem Biophys Res Commun. 2009. PMID: 19233133

2

A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system.

Kudoh H, Ikeda H, Kakitani M, Ueda A, Hayasaka M, Tomizuka K, Hanaoka K. Kudoh H, et al. Among authors: kakitani m. Biochem Biophys Res Commun. 2005 Mar 11;328(2):507-16. doi: 10.1016/j.bbrc.2004.12.191. Biochem Biophys Res Commun. 2005. PMID: 15694376

3

R-spondin1 plays an essential role in ovarian development through positively regulating Wnt-4 signaling.

Tomizuka K, Horikoshi K, Kitada R, Sugawara Y, Iba Y, Kojima A, Yoshitome A, Yamawaki K, Amagai M, Inoue A, Oshima T, Kakitani M. Tomizuka K, et al. Among authors: kakitani m. Hum Mol Genet. 2008 May 1;17(9):1278-91. doi: 10.1093/hmg/ddn036. Epub 2008 Feb 4. Hum Mol Genet. 2008. PMID: 18250097

4

Targeted deletion of the tybe IIb Na(+)-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality.

Shibasaki Y, Etoh N, Hayasaka M, Takahashi MO, Kakitani M, Yamashita T, Tomizuka K, Hanaoka K. Shibasaki Y, et al. Among authors: kakitani m. Biochem Biophys Res Commun. 2009 Apr 17;381(4):482-6. doi: 10.1016/j.bbrc.2009.02.067. Epub 2009 Feb 20. Biochem Biophys Res Commun. 2009. PMID: 19233126

5

R-Spondin proteins: a novel link to beta-catenin activation.

Kim KA, Zhao J, Andarmani S, Kakitani M, Oshima T, Binnerts ME, Abo A, Tomizuka K, Funk WD. Kim KA, et al. Among authors: kakitani m. Cell Cycle. 2006 Jan;5(1):23-6. doi: 10.4161/cc.5.1.2305. Epub 2006 Jan 8. Cell Cycle. 2006. PMID: 16357527

6

Mitogenic influence of human R-spondin1 on the intestinal epithelium.

Kim KA, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M, Liu Y, Boyle B, Park E, Emtage P, Funk WD, Tomizuka K. Kim KA, et al. Among authors: kakitani m. Science. 2005 Aug 19;309(5738):1256-9. doi: 10.1126/science.1112521. Science. 2005. PMID: 16109882

7

Adult-specific systemic over-expression reveals novel in vivo effects of the soluble forms of ActRIIA, ActRIIB and BMPRII.

Yamawaki K, Ueda S, Okada T, Oshima T, Kakitani M, Kato T, Tomizuka K. Yamawaki K, et al. Among authors: kakitani m. PLoS One. 2013 Oct 21;8(10):e78076. doi: 10.1371/journal.pone.0078076. eCollection 2013. PLoS One. 2013. PMID: 24205096 Free PMC article.

8

The soluble form of BMPRIB is a novel therapeutic candidate for treating bone related disorders.

Yamawaki K, Kondo Y, Okada T, Oshima T, Kakitani M, Tomizuka K. Yamawaki K, et al. Among authors: kakitani m. Sci Rep. 2016 Jan 6;6:18849. doi: 10.1038/srep18849. Sci Rep. 2016. PMID: 26732094 Free PMC article.

9

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T. Shimada T, et al. Among authors: kakitani m. J Clin Invest. 2004 Feb;113(4):561-8. doi: 10.1172/JCI19081. J Clin Invest. 2004. PMID: 14966565 Free PMC article.

10

Identification of osteoblast stimulating factor 5 as a negative regulator in the B-lymphopoietic niche.

Fujita N, Ichii M, Maeda T, Saitoh N, Yokota T, Yamawaki K, Kakitani M, Tomizuka K, Oritani K, Kanakura Y. Fujita N, et al. Among authors: kakitani m. Exp Hematol. 2015 Nov;43(11):963-973.e4. doi: 10.1016/j.exphem.2015.07.002. Epub 2015 Jul 23. Exp Hematol. 2015. PMID: 26213229 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page